APA (7th ed.) Citation

MD, H., CL, B., A, L., N, T., Z, I., ME, R., & M, S. (2020). Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab. Cancer treatment and research communications, 24, 100189. https://doi.org/10.1016/j.ctarc.2020.100189

Chicago Style (17th ed.) Citation

MD, Hackshaw, Bui CL, Ladner A, Tu N, Islam Z, Ritchey ME, and Salas M. "Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab." Cancer Treatment and Research Communications 24 (2020): 100189. https://doi.org/10.1016/j.ctarc.2020.100189.

MLA (9th ed.) Citation

MD, Hackshaw, et al. "Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab." Cancer Treatment and Research Communications, vol. 24, 2020, p. 100189, https://doi.org/10.1016/j.ctarc.2020.100189.